RobertAlanVigerskyMD
Endocrinology • Bethesda, MDDiabetes, Lipid Metabolism
Professor, Medicine, Uniformed Services Hebert SOM
Dr. Vigersky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8901 Wisconsin Ave
# 509
Bethesda, MD 20889Phone+1 301-295-5165Fax+1 301-295-5170
Education & Training
Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1972
Boston University School of MedicineClass of 1970
Certifications & Licensure
MD State Medical License 1976 - 2025
DC State Medical License 1978 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Continuous Glucose Monitoring in Patients With Type 2 Diabetes Start of enrollment: 2007 Sep 01
- Blood Sugar Response to Commercial Nutritional Supplements in Patients With Type 2 Diabetes Start of enrollment: 2006 May 01
- Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatment Start of enrollment: 2008 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsAssociation between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study.Yaxin Wang, Jingyi Lu, Jiaying Ni, Ming Wang, Yun Shen
Diabetes, Obesity & Metabolism. 2023-09-01 - 189 citationsShort- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 DiabetesRobert A. Vigersky, Stephanie J. Fonda, Mary Chellappa, M. Susan Walker, Nicole Ehrhardt
Diabetes Care. 2012-01-01 - 111 citationsThe Surveillance Error GridDavid C. Klonoff, Courtney Lias, Robert A. Vigersky, William L. Clarke, Joan Lee Parkes
Journal of Diabetes Science and Technology. 2014-06-13
Press Mentions
FDA Rules Medtronic’s Insulin Pump Issues a Class I Recall Due to Safety RisksOctober 4th, 2024- Increasing Access to Diabetes Technology for Children with Type 1 DiabetesMay 12th, 2023
- New High-Tech Tools to Help Control DiabetesApril 27th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
